The FDA granted emergency use authorization for a coronavirus antibody treatment made by Regeneron on Saturday. The treatment is the second antibody drug to receive emergency approval, and one of several treatments received by President Trump after he was diagnosed with the virus in October.
The New Paper
This story is from the November 23, 2020 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.
